KRAS and cancer: KRAS glycine 12 mutated to cysteine (KRAS[G12C]) is an activating KRAS mutant found in ∼12% of lung adenocarcinomas, ∼3% of colon cancers, and a lower frequency in pancreatic adenocarcinomas and other cancers.